Complete Filing Data
Olema Pharmaceuticals, Inc. reported Stockholders Equity of $478.56 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Olema Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$162.5M | -$129.5M | -$96.7M | -$104.8M | -$71.1M | -$22.1M | -$4.3M |
| Research And Development Expense | $157.7M | $124.5M | $86.1M | $82.3M | $51.1M | $13.7M | $3.9M |
| Operating Income Loss | -$178.7M | -$142.3M | -$105.0M | -$107.0M | -$71.5M | -$21.5M | -$4.3M |
| Operating Expenses | $178.7M | $142.3M | $105.0M | $107.0M | $71.5M | $21.5M | $4.3M |
| General And Administrative Expense | $21.0M | $17.7M | $18.8M | $24.7M | $20.4M | $7.8M | $403.0K |
| Comprehensive Income Net Of Tax | -$162.0M | -$129.7M | -$94.5M | -$106.5M | -$71.2M | -$22.1M | -$4.3M |
| Nonoperating Income Expense | $16.2M | $12.8M | $8.3M | $2.2M | $395.0K | -$593.0K | $7.0K |
| Other Nonoperating Income Expense | $23.0K | $102.0K | -$19.0K | -$27.0K | -$47.0K | ||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $478.0K | -$204.0K | $2.2M | -$1.7M | -$149.0K | ||
| Investment Income Nonoperating | $8.2M | $5.5M | $787.0K | ||||
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$71.1M | -$24.0M | -$4.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$42.2M | -$43.8M | -$30.4M | -$34.6M | -$30.4M | -$31.0M | -$21.5M | -$20.1M | -$28.3M | -$22.7M | -$32.9M | -$23.0M | -$17.7M | -$16.4M | -$15.3M | -$7.8M | -$2.5M | -$1.7M |
| Research And Development Expense | $40.0M | $43.9M | $30.6M | $33.2M | $29.1M | $29.9M | $19.5M | $18.0M | $22.8M | $17.6M | $27.1M | $16.0M | $12.5M | $11.9M | $10.7M | $4.7M | $1.9M | $795.0K |
| Operating Income Loss | -$45.9M | -$47.9M | -$34.9M | -$37.6M | -$33.5M | -$34.3M | -$23.3M | -$21.6M | -$29.6M | -$23.2M | -$33.3M | -$23.3M | -$17.8M | -$16.5M | -$15.5M | -$7.9M | -$2.5M | -$1.0M |
| Operating Expenses | $45.9M | $47.9M | $34.9M | $37.6M | $33.5M | $34.3M | $23.3M | $21.6M | $29.6M | $23.2M | $33.3M | $23.3M | $17.8M | $16.5M | $15.5M | $7.9M | $2.5M | $1.0M |
| General And Administrative Expense | $5.9M | $4.0M | $4.2M | $4.4M | $4.4M | $4.5M | $3.9M | $3.6M | $6.8M | $5.6M | $6.2M | $7.2M | $5.2M | $4.6M | $4.8M | $3.2M | $539.0K | $248.0K |
| Comprehensive Income Net Of Tax | -$42.0M | -$43.9M | -$30.1M | -$34.0M | -$30.5M | -$31.3M | -$21.2M | -$19.6M | -$27.5M | -$23.0M | -$33.6M | -$24.5M | -$17.7M | -$16.4M | -$15.4M | -$7.8M | -$2.5M | -$1.7M |
| Nonoperating Income Expense | $3.7M | $4.1M | $4.5M | $3.1M | $3.1M | $3.4M | $1.8M | $1.5M | $1.3M | $502.0K | $435.0K | $224.0K | $49.0K | $116.0K | $111.0K | $24.0K | $33.0K | |
| Other Nonoperating Income Expense | $12.0K | $38.0K | -$40.0K | $138.0K | $40.0K | $17.0K | -$79.0K | -$44.0K | $11.0K | -$120.0K | $20.0K | $6.0K | -$56.0K | -$1.0K | $111.0K | $1.0K | -$650.0K | |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $212.0K | -$106.0K | $277.0K | $582.0K | -$108.0K | -$357.0K | $277.0K | $460.0K | $835.0K | -$276.0K | -$772.0K | -$1.5M | $29.0K | -$1.0K | -$13.0K | |||
| Investment Income Nonoperating | $2.1M | $2.4M | $869.0K | |||||||||||||||
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax | $212.0K | -$106.0K | $582.0K | -$108.0K | ||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$17.7M | -$9.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $478.6M | $409.0M | $253.9M | $197.5M | $284.6M | $338.1M | -$10.6M | -$8.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $48.3M | $139.5M | $68.5M | $23.7M | $13.8M | $338.5M | $68.0K | $3.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$91.2M | $70.9M | $44.8M | $9.9M | -$324.7M | $338.5M | -$3.1M | |
| Retained Earnings Accumulated Deficit | -$597.6M | -$435.1M | -$305.6M | -$209.0M | -$104.2M | -$33.1M | ||
| Prepaid Expense And Other Assets Current | $10.0M | $4.4M | $4.7M | $4.5M | $3.4M | $3.6M | ||
| Liabilities Current | $51.8M | $41.8M | $21.6M | $16.5M | $9.0M | $4.6M | ||
| Liabilities And Stockholders Equity | $533.4M | $451.0M | $276.9M | $215.6M | $295.9M | $342.7M | ||
| Liabilities | $54.9M | $42.0M | $23.1M | $18.1M | $11.4M | $4.6M | ||
| Common Stock Value | $8.0K | $7.0K | $4.0K | $3.0K | $3.0K | $3.0K | ||
| Cash And Cash Equivalents At Carrying Value | $48.3M | $139.5M | $68.5M | $23.7M | $13.8M | $338.5M | ||
| Assets Current | $515.5M | $438.5M | $266.5M | $208.9M | $290.7M | $342.1M | ||
| Assets | $533.4M | $451.0M | $276.9M | $215.6M | $295.9M | $342.7M | ||
| Accounts Payable Current | $9.3M | $4.5M | $2.7M | $374.0K | $23.0K | $719.0K | ||
| Other Liabilities Current | $41.4M | $36.1M | $17.9M | $15.2M | $8.1M | $3.9M | ||
| Marketable Securities Current | $457.1M | $294.6M | $193.3M | $180.7M | $273.4M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $621.0K | $143.0K | $347.0K | -$1.8M | -$149.0K | |||
| Operating Lease Right Of Use Asset | $1.1M | $1.3M | $2.3M | $2.5M | $3.2M | |||
| Operating Lease Liability Noncurrent | $69.0K | $257.0K | $1.4M | $1.6M | $2.4M | |||
| Operating Lease Liability Current | $1.1M | $1.2M | $988.0K | $1.0M | $931.0K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $1.2M | $1.2M | $1.3M | $1.3M | $1.2M | |||
| Property Plant And Equipment Net | $1.5M | $75.0K | ||||||
| Other Assets And Long Term Deposits Non Current | $16.8M | $11.2M | $8.1M | $4.3M | ||||
| Other Assets Noncurrent | $540.0K | $510.0K | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $787.0K | -$276.0K | ||||||
| Stock Issued Under Equity At The Market Offering Value | $22.8M | |||||||
| Gain Loss On Disposition Of Assets1 | -$9.0K | -$111.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $307.5M | $345.2M | $383.5M | $198.9M | $227.2M | $236.3M | $275.1M | $161.6M | $175.0M | $217.7M | $236.3M | $265.1M | $300.9M | $314.1M | $326.0M | -$23.0M | -$14.0M | -$11.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $35.3M | $52.5M | $50.6M | $35.9M | $16.9M | $33.7M | $117.4M | $35.0M | $40.9M | $26.8M | $24.5M | $21.5M | $25.6M | $50.4M | $47.9M | $127.8M | $50.5M | $27.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$88.8M | -$34.8M | $17.2M | $7.7M | -$290.7M | $27.8M | |||||||||||||
| Retained Earnings Accumulated Deficit | -$551.5M | -$509.3M | -$465.5M | -$401.5M | -$367.0M | -$336.6M | -$278.9M | -$257.4M | -$237.3M | -$182.8M | -$160.1M | -$127.2M | -$82.6M | -$64.8M | -$48.4M | ||||
| Prepaid Expense And Other Assets Current | $5.4M | $5.8M | $4.0M | $3.2M | $3.1M | $3.1M | $5.1M | $4.1M | $3.4M | $2.5M | $2.3M | $2.3M | $2.3M | $2.7M | $3.3M | ||||
| Liabilities Current | $41.7M | $33.2M | $26.1M | $30.7M | $26.5M | $26.2M | $16.0M | $14.8M | $19.4M | $12.6M | $12.3M | $10.2M | $8.9M | $8.1M | $5.3M | ||||
| Liabilities And Stockholders Equity | $352.5M | $382.0M | $409.6M | $230.2M | $254.6M | $263.7M | $292.8M | $177.6M | $195.8M | $232.0M | $250.6M | $277.4M | $309.8M | $322.2M | $331.3M | ||||
| Liabilities | $45.0M | $36.8M | $26.2M | $31.3M | $27.4M | $27.4M | $17.7M | $16.0M | $20.8M | $14.3M | $14.3M | $12.3M | $8.9M | $8.1M | $5.3M | ||||
| Common Stock Value | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $35.3M | $52.5M | $50.6M | $35.9M | $16.9M | $33.7M | $117.4M | $35.0M | $40.9M | $26.8M | $24.5M | $21.5M | $25.6M | $50.4M | $47.9M | ||||
| Assets Current | $334.3M | $367.7M | $396.7M | $218.0M | $242.2M | $252.1M | $282.0M | $171.5M | $189.4M | $225.1M | $243.0M | $270.2M | $308.3M | $320.9M | $330.3M | ||||
| Assets | $352.5M | $382.0M | $409.6M | $230.2M | $254.6M | $263.7M | $292.8M | $177.6M | $195.8M | $232.0M | $250.6M | $277.4M | $309.8M | $322.2M | $331.3M | ||||
| Accounts Payable Current | $3.5M | $934.0K | $151.0K | $2.7M | $4.4M | $7.7M | $2.2M | $1.6M | $681.0K | $14.0K | $120.0K | $268.0K | $306.0K | $385.0K | $419.0K | ||||
| Other Liabilities Current | $37.0M | $31.1M | $24.9M | $26.9M | $21.1M | $17.5M | $17.8M | $11.5M | $11.1M | $9.0M | $8.6M | $7.8M | $4.9M | ||||||
| Marketable Securities Current | $293.7M | $309.4M | $342.1M | $178.9M | $222.2M | $215.3M | $159.5M | $132.5M | $145.0M | $195.8M | $216.2M | $246.4M | $280.4M | $267.7M | $279.1M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $526.0K | $314.0K | $420.0K | $464.0K | -$118.0K | -$10.0K | -$241.0K | -$518.0K | -$978.0K | -$2.7M | -$2.4M | -$1.6M | $15.0K | -$14.0K | -$13.0K | ||||
| Operating Lease Right Of Use Asset | $1.4M | $1.7M | $1.1M | $1.6M | $1.8M | $2.1M | $2.6M | $1.9M | $2.2M | $2.8M | $3.0M | $3.0M | |||||||
| Operating Lease Liability Noncurrent | $310.0K | $602.0K | $123.0K | $562.0K | $859.0K | $1.2M | $1.7M | $1.2M | $1.4M | $1.7M | $2.0M | $2.2M | |||||||
| Operating Lease Liability Current | $1.2M | $1.2M | $1.0M | $1.1M | $1.1M | $1.1M | $924.0K | $798.0K | $908.0K | $1.1M | $1.1M | $881.0K | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $287.0K | $288.0K | $327.0K | $323.0K | |||||||||||||||
| Property Plant And Equipment Net | $1.1M | $1.3M | $1.4M | $1.5M | $1.4M | $1.5M | $1.4M | $975.0K | $866.0K | $526.0K | |||||||||
| Other Assets And Long Term Deposits Non Current | $16.7M | $12.6M | $11.9M | $10.6M | $10.6M | $9.5M | $7.2M | $2.9M | |||||||||||
| Other Assets Noncurrent | $2.8M | $2.8M | $2.8M | $3.1M | $2.8M | $540.0K | $510.0K | $510.0K | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $869.0K | -$6.0K | -$64.0K | ||||||||||||||||
| Stock Issued Under Equity At The Market Offering Value | $14.9M | $7.9M | |||||||||||||||||
| Gain Loss On Disposition Of Assets1 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $17.6M | $573.0K | $452.0K | $376.0K | $233.0K | $30.0K | |
| Proceeds From Stock Options Exercised | $8.4M | $1.7M | $2.6M | $146.0K | $670.0K | $641.0K | |
| Net Cash Provided By Used In Operating Activities | -$146.7M | -$104.4M | -$83.7M | -$82.1M | -$50.7M | -$19.9M | -$3.1M |
| Increase Decrease In Accounts Payable | $4.6M | $2.5M | $2.3M | $351.0K | -$683.0K | -$220.0K | $810.0K |
| Depreciation Depletion And Amortization | $490.0K | $393.0K | $377.0K | $357.0K | $163.0K | $11.0K | $9.0K |
| Net Cash Provided By Used In Investing Activities | -$155.8M | -$93.5M | -$4.9M | $91.5M | -$275.4M | -$56.0K | |
| Share Based Compensation | $17.6M | $22.6M | $17.3M | $18.8M | $15.9M | $3.1M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.4M | $429.0K | -$694.0K | $2.0M | $40.0K | $3.6M | -$58.0K |
| Net Cash Provided By Used In Financing Activities | $211.3M | $268.8M | $133.4M | $476.0K | $1.4M | $358.4M | |
| Increase Decrease In Other Current Liabilities | $11.0M | $11.2M | $2.9M | $7.0M | $4.6M | $2.8M | $358.0K |
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Value | $80.0K | $124.0K | $372.0K | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $345.0M | $301.6M | $250.8M | $305.5M | $213.1M | ||
| Payments To Acquire Marketable Securities | $500.7M | $395.0M | $255.6M | $213.7M | $487.0M | ||
| Payments To Acquire Property Plant And Equipment | $159.0K | $363.0K | $1.6M | $56.0K | |||
| Increase Decrease In Operating Lease Liability | -$1.2M | -$1.2M | -$1.2M | -$1.3M | -$988.0K | ||
| Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan | $1.0M | $859.0K | $1.1M | $330.0K | $721.0K | ||
| Increase Decrease In Other Non Current Assets And Long Term Deposits | $6.1M | $3.0M | $5.3M | $1.1M | |||
| Payments Of Stock Issuance Costs | $264.0K | ||||||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period | $197.3K | $242.1K | |||||
| Proceeds From Issuance Of Shares Under At The Market Offering | 22.8M | ||||||
| Increase Decrease In Other Operating Assets | $1.1M | $30.0K | $507.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $183.0K | $54.0K | $182.0K | $205.0K | $86.0K | $130.0K | $115.0K | $68.0K | $105.0K | $91.0K | $32.0K | $50.0K | $64.0K | |
| Proceeds From Stock Options Exercised | $236.0K | $920.0K | $220.0K | $33.0K | ||||||||||
| Net Cash Provided By Used In Operating Activities | -$44.0M | -$23.5M | -$20.4M | -$17.9M | -$11.1M | -$2.1M | ||||||||
| Increase Decrease In Accounts Payable | -$4.3M | $5.0M | $307.0K | $245.0K | -$327.0K | -$725.0K | ||||||||
| Depreciation Depletion And Amortization | $128.0K | $88.0K | $100.0K | $84.0K | $9.0K | $3.0K | ||||||||
| Net Cash Provided By Used In Investing Activities | -$45.1M | -$20.1M | $37.4M | $25.6M | -$279.6M | -$9.0K | ||||||||
| Share Based Compensation | $4.4M | $4.9M | $4.6M | $5.0M | $3.2M | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$549.0K | -$1.6M | -$1.0M | -$172.0K | -$291.0K | $390.0K | ||||||||
| Net Cash Provided By Used In Financing Activities | $222.0K | $8.8M | $220.0K | $33.0K | $30.0M | |||||||||
| Increase Decrease In Other Current Liabilities | -$11.2M | -$404.0K | $2.7M | -$113.0K | $1.0M | $28.0K | ||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Value | $20.0K | $30.0K | $30.0K | $31.0K | $31.0K | $31.0K | $280.0K | $30.0K | $31.0K | |||||
| Proceeds From Sale And Maturity Of Marketable Securities | $97.8M | $56.1M | $61.8M | $148.8M | $1.0M | |||||||||
| Payments To Acquire Marketable Securities | $142.9M | $76.1M | $24.4M | $123.2M | $280.2M | |||||||||
| Payments To Acquire Property Plant And Equipment | $153.0K | $30.0K | $420.0K | $9.0K | ||||||||||
| Increase Decrease In Operating Lease Liability | -$309.0K | -$260.0K | -$326.0K | -$315.0K | ||||||||||
| Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan | ||||||||||||||
| Increase Decrease In Other Non Current Assets And Long Term Deposits | $965.0K | $1.3M | ||||||||||||
| Payments Of Stock Issuance Costs | $25.0K | $166.0K | $240.0K | |||||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period | $49.3K | $49.3K | $26.9K | |||||||||||
| Proceeds From Issuance Of Shares Under At The Market Offering | 7.9M | |||||||||||||
| Increase Decrease In Other Operating Assets | $240.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.87 | -$2.20 | -$2.14 | -$2.62 | -$1.80 | -$3.42 | -$1.66 |
| Weighted Average Number Of Shares Outstanding Basic | 87.0M | 58.7M | 45.2M | 40.0M | 39.5M | 7.0M | 2.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 87.0M | 58.7M | 45.2M | 40.0M | 39.5M | 7.0M | 2.6M |
| Earnings Per Share Basic | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | $-1.66 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Outstanding | 81.4M | 74.3M | 55.0M | 40.3M | 39.8M | 39.3M | |
| Common Stock Shares Issued | 81.4M | 74.3M | 55.1M | 40.6M | 40.3M | 40.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.49 | -$0.51 | -$0.36 | -$0.60 | -$0.54 | -$0.56 | -$0.48 | -$0.49 | -$0.70 | -$0.57 | -$0.82 | -$0.58 | -$0.45 | -$0.42 | -$0.39 | -$3.71 | -$0.95 | -$0.65 |
| Weighted Average Number Of Shares Outstanding Basic | 85.7M | 85.5M | 85.4M | 57.3M | 56.3M | 55.6M | 45.0M | 40.7M | 40.4M | 40.0M | 39.9M | 39.8M | 39.6M | 39.4M | 39.3M | 2.6M | 2.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 85.7M | 85.5M | 85.4M | 57.3M | 56.3M | 55.6M | 45.0M | 40.7M | 40.4M | 40.0M | 39.9M | 39.8M | 39.6M | 39.4M | 39.3M | 2.6M | 2.6M | |
| Earnings Per Share Basic | $-0.49 | $-0.51 | $-0.36 | $-0.60 | $-0.54 | $-0.56 | $-0.48 | $-0.49 | $-0.70 | $-0.57 | $-0.82 | $-0.58 | $-0.45 | $-0.42 | $-0.39 | $-3.71 | $-0.95 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Common Stock Shares Outstanding | 68.7M | 68.6M | 68.3M | 57.3M | 57.2M | 55.9M | 54.6M | 41.1M | 40.4M | 40.1M | 40.0M | 39.9M | 39.7M | 39.6M | 39.3M | |||
| Common Stock Shares Issued | 68.7M | 68.6M | 68.3M | 57.3M | 57.3M | 55.9M | 54.7M | 41.3M | 40.7M | 40.5M | 40.4M | 40.4M | 40.3M | 40.3M | 40.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Investment Income Interest | $16.2M | $12.7M | $8.3M | $2.2M | $442.0K | $60.0K | $7.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $22.0M | $16.8M | $18.5M | $15.7M | $3.1M | ||
| Stock Issued During Period Value Stock Options Exercised | $8.2M | $1.5M | $2.7M | $146.0K | $670.0K | $151.0K | |
| Additional Paid In Capital | $1.08B | $843.9M | $559.2M | $408.3M | $388.9M | $371.2M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.0M | $859.0K | $1.1M | $330.0K | $721.0K | ||
| Stock Issued During Period Shares Stock Options Exercised | 1.4M | 460.7K | 774.1K | 115.4K | 206.5K | 135.5K | |
| Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares | 2.2M | 2.3M | 1.7M | 1.3M | 426.7K | 2.9K | |
| Vesting Of Early Exercised Stock Options | $124.0K | $372.0K | $41.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $3.6M | $4.0M | $4.5M | $2.9M | $3.1M | $3.4M | $1.9M | $1.6M | $1.3M | $622.0K | $415.0K | $218.0K | $105.0K | $117.0K | $111.0K | $23.0K | $33.0K | $3.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.3M | $4.7M | $4.2M | $5.6M | $5.5M | $4.7M | $4.0M | $4.0M | $4.5M | $4.2M | $4.6M | $4.9M | $4.1M | $3.9M | $3.1M | $582.0K | $154.0K | |
| Stock Issued During Period Value Stock Options Exercised | $7.0K | $234.0K | $236.0K | $95.0K | $75.0K | $940.0K | $891.0K | $1.3M | $220.0K | $106.0K | $7.0K | $33.0K | $57.0K | $130.0K | $120.0K | |||
| Additional Paid In Capital | $858.5M | $854.2M | $848.5M | $600.0M | $594.3M | $572.9M | $554.2M | $419.5M | $413.2M | $403.2M | $398.8M | $393.9M | $383.4M | $378.9M | $374.5M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $748.0K | $650.0K | $711.0K | $57.0K | $386.0K | |||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 90.5K | 308.6K | 101.9K | 22.7K | ||||||||||||||
| Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares | 95.9K | 16.3K | ||||||||||||||||
| Vesting Of Early Exercised Stock Options | $31.0K | $31.0K |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.